Compare AEHL & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AEHL | LENZ |
|---|---|---|
| Founded | 1993 | 2019 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Building Materials | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.4M | 106.8M |
| IPO Year | 2009 | 2021 |
| Metric | AEHL | LENZ |
|---|---|---|
| Price | $10.25 | $4.08 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $14.83 |
| AVG Volume (30 Days) | ★ 1.5M | 1.2M |
| Earning Date | 07-06-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $19,088,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $125.50 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.27 | $2.80 |
| 52 Week High | $30.60 | $32.13 |
| Indicator | AEHL | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 51.66 | 58.80 |
| Support Level | $0.83 | $3.60 |
| Resistance Level | $16.79 | $6.11 |
| Average True Range (ATR) | 1.95 | 0.38 |
| MACD | 0.25 | 0.15 |
| Stochastic Oscillator | 31.56 | 81.53 |
Antelope Enterprise Holdings Ltd operates in three reportable operating segments: Business Management Consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting; Natural Gas Power generation, which was in the initial development stage; and Live-Streaming e-commerce segment, providing a one-stop solution for customers to enable them to utilize the growing sales channel of livestreaming ecommerce. The business of the Company is engaged in the PRC and the United States.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.